Benzinga's Volume Movers
Vertex Pharmaceuticals (NASDAQ: VRTX) shares moved up 41.68% to $94.37. The volume of Vertex Pharmaceuticals shares traded was 2978% higher than normal. Vertex Pharma reported that its two phase 3 study of Lumacaftor in combination with ivacaftor met the primary endpoint.
TG Therapeutics (NASDAQ: TGTX) shares rose 6.91% to $10.36. The volume of TG Therapeutics shares traded was 442% higher than normal. TG Therapeutics completed a licensing agreement with Ligand Pharma (NASDAQ: LGND) to develop inhibitors of IRAK4.
Wix.com (NASDAQ: WIX) surged 6.87% to $18.99. The volume of Wix.com shares traded 333% higher than normal. Wix.com announced that it had surpassed 50 million registered users worldwide.
Voxeljet AG (NASDAQ: VJET) shares climbed 3.71% to $18.15. The volume of Voxeljet shares traded was 200% higher than normal. Voxeljet's trailing-twelve-month revenue is $16.39 million.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.